Header cover image

Australian (ASX) Clinical Research and Equipment Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies8
  • 7D-4.0%
  • 3M12.6%
  • 1Y-17.1%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 6.1%, driven by Trajan Group Holdings declining 4.8%. Meanwhile, Cryosite actually outperformed within the industry, gaining 18% in the last week. Overall the industry is down 14% in 12 months. Earnings are forecast to grow by 76% annually.

Industry Valuation and Performance

Has the Australian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024AU$558.8mAU$246.1m-AU$49,506,434.0019.1x-11.3x2.3x
Sun, 24 Mar 2024AU$519.8mAU$246.1m-AU$49,506,434.0013.7x-10.5x2.1x
Tue, 20 Feb 2024AU$488.9mAU$248.2m-AU$39,797,313.0021.8x-12.3x2x
Thu, 18 Jan 2024AU$467.0mAU$248.2m-AU$39,797,313.0025.8x-11.7x1.9x
Sat, 16 Dec 2023AU$541.8mAU$248.6m-AU$52,451,569.0022.5x-10.3x2.2x
Mon, 13 Nov 2023AU$548.0mAU$248.6m-AU$52,451,569.0019.7x-10.4x2.2x
Wed, 11 Oct 2023AU$540.8mAU$248.6m-AU$52,451,569.0022.5x-10.3x2.2x
Fri, 08 Sep 2023AU$578.7mAU$248.8m-AU$52,451,569.0022.7x-11x2.3x
Sun, 06 Aug 2023AU$661.7mAU$221.5m-AU$37,611,177.0025.2x-17.6x3x
Tue, 04 Jul 2023AU$647.6mAU$221.5m-AU$37,611,177.0024.2x-17.2x2.9x
Thu, 01 Jun 2023AU$624.9mAU$221.5m-AU$37,611,177.0019.9x-16.6x2.8x
Sat, 29 Apr 2023AU$652.7mAU$221.5m-AU$37,611,177.0030.6x-17.4x2.9x
Mon, 27 Mar 2023AU$694.3mAU$221.7m-AU$39,169,534.0030.2x-17.7x3.1x
Wed, 22 Feb 2023AU$757.2mAU$184.6m-AU$29,264,632.0033.1x-25.9x4.1x
Fri, 20 Jan 2023AU$815.4mAU$184.6m-AU$29,264,632.0035.6x-27.9x4.4x
Sun, 18 Dec 2022AU$762.4mAU$184.6m-AU$29,264,632.0033.1x-26.1x4.1x
Tue, 15 Nov 2022AU$738.0mAU$184.6m-AU$29,264,632.0028.4x-25.2x4x
Thu, 13 Oct 2022AU$783.7mAU$184.6m-AU$29,264,632.0032.4x-26.8x4.2x
Sat, 10 Sep 2022AU$840.1mAU$185.8m-AU$29,264,632.0034x-28.7x4.5x
Mon, 08 Aug 2022AU$882.5mAU$150.4m-AU$31,222,532.0028x-28.3x5.9x
Wed, 06 Jul 2022AU$891.6mAU$150.4m-AU$31,222,532.0028.4x-28.6x5.9x
Fri, 03 Jun 2022AU$986.7mAU$150.4m-AU$31,222,532.0023.6x-31.6x6.6x
Sun, 01 May 2022AU$1.2bAU$150.2m-AU$30,481,316.0025.9x-39.4x8x
Tue, 29 Mar 2022AU$1.2bAU$167.1m-AU$90,069,489.0019.9x-13.2x7.1x
Thu, 24 Feb 2022AU$1.4bAU$163.5m-AU$82,957,492.0061.8x-16.7x8.5x
Sat, 22 Jan 2022AU$1.9bAU$138.2m-AU$84,243,063.00117.5x-22.2x13.6x
Mon, 20 Dec 2021AU$1.4bAU$138.2m-AU$84,243,063.00105.1x-16.9x10.3x
Wed, 17 Nov 2021AU$1.4bAU$138.3m-AU$81,930,910.0077.9x-17.3x10.3x
Fri, 15 Oct 2021AU$1.4bAU$138.2m-AU$84,243,063.00113.3x-16.6x10.1x
Sun, 12 Sep 2021AU$1.5bAU$138.2m-AU$84,243,063.00126.1x-18x10.9x
Tue, 10 Aug 2021AU$1.4bAU$148.9m-AU$96,965,525.0081.7x-14.6x9.5x
Mon, 03 May 2021AU$1.5bAU$78.7m-AU$82,853,575.0041.1x-18.5x19.5x
Price to Earnings Ratio

-18.5x


Total Market Cap: AU$1.5bTotal Earnings: -AU$82,853,575.00Total Revenue: AU$78.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Clinical Research and Equipment Industry Price to Earnings3Y Average -19.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Australian Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.1x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
  • Revenues for these companies have grown 46% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Australian Clinical Research and Equipment compare with similar industries?

AU Market0.42%
Healthcare2.56%
Life Sciences-4.04%
Clinical Research and Equipment-4.04%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CTE CryositeAU$0.8717.6%
+AU$6.3m
16.0%PE26.9x
EZZ EZZ Life Science HoldingsAU$0.894.7%
+AU$1.8m
50.0%PE11.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.